In the context of CVD, the activation of the NLRP3 inflammasome in macrophages, with the consequent release of IL-1β, has been shown to be implicated in the development of atherosclerosis and the clinical manifestations of the disease [30]. The gene discussed is NLRP3; the disease is atherosclerosis.